Author: Charmaine Fraser

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased is pleased to provide shareholders with an update on the Company's operational progress and strategic development.   The Company continues to make strong operational progress as it executes on its strategic priorities and works to strengthen the foundations of the business for...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to highlight the development of a hantavirus translational modelling framework demonstrating the Company's quantitative pharmacology and mechanistic modelling capabilities within infectious disease applications. The framework illustrates how Physiomics can integrate multiple evidence layers into a coherent translational workflow, linking:   in vitro...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that so far this month, it has secured multiple new contract awards with a combined value of over £345,000.   The awards comprise a combination of new and follow-on engagements with respected UK and international biotechnology and oncology-focused organisations, including...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that Peter Sargent has agreed to extend his existing agreement with the Company and remain in his current role throughout June 2026.   The Board and Dr Sargent remain in ongoing discussions regarding a potentially longer-term continuation of his involvement,...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce the appointment of Stewart Williams FCILT as a consultant to the Company.   Mr Williams will support the Board and management team during the Company’s senior leadership transition, providing strategic, operational and programme delivery expertise to assist with the ongoing...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that the newly appointed Board has commenced an extensive review of the business with a clear focus on operational optimisation, commercial execution, and shareholder value creation.   The Board believes the Company possesses a number of underappreciated strengths, including an...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announces that all resolutions (“Resolutions”) put to shareholders at the general meeting, called by Mr Michael Whitlow, held today (“General Meeting”) were passed.   Click here to read in full...